Nanobiotix's American depositary receipts climbed after the company completed the Phase 1 study of its pancreatic cancer treatment. The stock was up 18% at $3.55 in premarket trading. Shares had ...
Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial,” published in the December 2024 issue of Oncology by ...
Investigators concluded that the encouraging oncologic outcomes coupled with a favorable safety profile warrant further ...
Judge Azura Alwi allowed the application following submissions by Muhyiddin's lawyer Datuk Hisyam Teh Poh Teik, who requested ...
A pancreatic cancer diagnosis can be startling. One young survivor, who battled this disease during the COVID-19 pandemic, shares how he overcame the odds: "Every day is a gift." ...
MIAMI - Not long ago, a Stage 4 pancreatic cancer diagnosis was considered a death sentence. But survival rates are improving and one Miami man is living proof! Manny Garcia has a second chance at ...
Investigators concluded that the encouraging oncologic outcomes coupled with a favorable safety profile warrant further evaluation in a randomized trial23 months median Overall Survival from date of ...
Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, ...
The Sessions Court today granted Tan Sri Muhyiddin Yassin a temporary release of his international passport for a medical ...
An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) ...
Cardiff Oncology has had a stellar year, with its stock price up a striking +64.86% year-to-date (YTD). This growth outpaces the broader market by a wide margin, especially when compared to the S&P ...